Pharma BD Deal Intelligence
Bayer AG / Monsanto Company
2016 · Acquisition/Merger · $63.0B · Complete
Announcement Sentiment
38
Skeptical
Outcome Score
35
Underwhelmed — fell short of the thesis.
Bayer acquired Monsanto for $63 billion ($128 per share) in an all-cash transaction, creating a global leader in agriculture and life sciences. The deal faced extensive regulatory review and required significant divestitures.
Did it work? Outcome assessment Roundup litigation cost $20B+ settlements, $12.9B write-downs, 70% market cap destroyed
Strategic verdict
Failed to Achieve
Assessment window: 15yr post-close.
Key facts
Announced Sep 14, 2016 Closed Jun 07, 2018 Deal value $63.0B Deal type Acquisition/Merger Key assets Monsanto seed portfolio, Roundup herbicide, Agricultural biotech platform
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals
The Pharma Closeout — Deal Intelligence Database.
Announcement Sentiment and Outcome Score from sourced facts.Home ·
Deals ·
Methodology ·
About